Costs of treatment of haemophilia A in Italy: comparison of the use of plasma-derived and recombinant FVIII using a discrete event simulation (DES) model
Farmeconomia. Health economics and therapeutic pathways · 2013
DOI: 10.7175/fe.65114251-74 ↗Kurz gefasst
Fachartikel in der Zeitschrift Farmeconomia. Health economics and therapeutic pathways, 2013. Verfasst von Mario Eandi und 2 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Eandi, M., Pradelli, L., & Povero, M. (2013). Costs of treatment of haemophilia A in Italy: comparison of the use of plasma-derived and recombinant FVIII using a discrete event simulation (DES) model. Farmeconomia. Health economics and therapeutic pathways. https://doi.org/10.7175/fe.65114251-74
Vancouver
Eandi M, Pradelli L, Povero M. Costs of treatment of haemophilia A in Italy: comparison of the use of plasma-derived and recombinant FVIII using a discrete event simulation (DES) model. Farmeconomia. Health economics and therapeutic pathways. 2013. doi:10.7175/fe.65114251-74
BibTeX
@article{Eandi2013,
author = {Eandi, Mario and Pradelli, Lorenzo and Povero, Massimiliano},
title = {Costs of treatment of haemophilia A in Italy: comparison of the use of plasma-derived and recombinant FVIII using a discrete event simulation (DES) model},
journal = {Farmeconomia. Health economics and therapeutic pathways},
year = {2013},
doi = {10.7175/fe.65114251-74}
}
EUVIMED